Low-dose radiation for early Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests if giving very low doses of radiation to the brain could boost the immune system and slow down early Alzheimer's disease. It aims to see if this treatment is safe and possibly helpful for people with early symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Alzheimer's disease, and it started before age 65.
- You are older than 50 years.
- You have been taking the same Alzheimer's medication for at least 3 months without changes.
- You are able to understand the study and give your consent.
- You do not have mild memory problems (called mild cognitive impairment) or other conditions that might interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if very low doses of radiation to the brain can reduce inflammation and slow memory loss in people with Alzheimer's or similar dementias. It involves monthly clinic visits for a year.
This study tests a low dose of radiation to the whole brain combined with an experimental drug to see if it can slow down the effects of mild Alzheimer's disease. It aims to help people with mild dementia think more clearly and keep their daily abilities for as long as possible.
This study tests whether using a very low dose of radiation for a brain PET scan can still give clear images. If you are eligible, you will get a type of radioactive tracer that helps show amyloid plaques in the brain, often used in Alzheimer's research.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This trial tests a treatment that sends gentle electrical pulses to a part of the brain involved in memory and thinking. It is for people with early-stage Alzheimer's who live at home and have a caregiver who can help.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.